IBDEI04V ; ; 19-NOV-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,6200,2)
 ;;=^67056
 ;;^UTILITY(U,$J,358.3,6201,0)
 ;;=597.80^^37^438^23
 ;;^UTILITY(U,$J,358.3,6201,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6201,1,3,0)
 ;;=3^597.80
 ;;^UTILITY(U,$J,358.3,6201,1,4,0)
 ;;=4^URETHRITIS NOS
 ;;^UTILITY(U,$J,358.3,6201,2)
 ;;=^124214
 ;;^UTILITY(U,$J,358.3,6202,0)
 ;;=788.30^^37^438^25
 ;;^UTILITY(U,$J,358.3,6202,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6202,1,3,0)
 ;;=3^788.30
 ;;^UTILITY(U,$J,358.3,6202,1,4,0)
 ;;=4^URINARY INCONTINENCE
 ;;^UTILITY(U,$J,358.3,6202,2)
 ;;=^124400
 ;;^UTILITY(U,$J,358.3,6203,0)
 ;;=599.0^^37^438^24
 ;;^UTILITY(U,$J,358.3,6203,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6203,1,3,0)
 ;;=3^599.0
 ;;^UTILITY(U,$J,358.3,6203,1,4,0)
 ;;=4^URIN TRACT INFECTION NOS
 ;;^UTILITY(U,$J,358.3,6203,2)
 ;;=^124436
 ;;^UTILITY(U,$J,358.3,6204,0)
 ;;=585.1^^37^438^2
 ;;^UTILITY(U,$J,358.3,6204,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6204,1,3,0)
 ;;=3^585.1
 ;;^UTILITY(U,$J,358.3,6204,1,4,0)
 ;;=4^CHR KIDNEY DIS STAGE I
 ;;^UTILITY(U,$J,358.3,6204,2)
 ;;=^332807
 ;;^UTILITY(U,$J,358.3,6205,0)
 ;;=585.2^^37^438^3
 ;;^UTILITY(U,$J,358.3,6205,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6205,1,3,0)
 ;;=3^585.2
 ;;^UTILITY(U,$J,358.3,6205,1,4,0)
 ;;=4^CHR KIDNEY DIS STAGE II
 ;;^UTILITY(U,$J,358.3,6205,2)
 ;;=^332808
 ;;^UTILITY(U,$J,358.3,6206,0)
 ;;=585.3^^37^438^4
 ;;^UTILITY(U,$J,358.3,6206,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6206,1,3,0)
 ;;=3^585.3
 ;;^UTILITY(U,$J,358.3,6206,1,4,0)
 ;;=4^CHR KIDNEY DIS STAGE III
 ;;^UTILITY(U,$J,358.3,6206,2)
 ;;=^332809
 ;;^UTILITY(U,$J,358.3,6207,0)
 ;;=585.4^^37^438^5
 ;;^UTILITY(U,$J,358.3,6207,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6207,1,3,0)
 ;;=3^585.4
 ;;^UTILITY(U,$J,358.3,6207,1,4,0)
 ;;=4^CHR KIDNEY DIS STAGE IV
 ;;^UTILITY(U,$J,358.3,6207,2)
 ;;=^332810
 ;;^UTILITY(U,$J,358.3,6208,0)
 ;;=585.5^^37^438^6
 ;;^UTILITY(U,$J,358.3,6208,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6208,1,3,0)
 ;;=3^585.5
 ;;^UTILITY(U,$J,358.3,6208,1,4,0)
 ;;=4^CHR KIDNEY DIS STAGE V
 ;;^UTILITY(U,$J,358.3,6208,2)
 ;;=^332811
 ;;^UTILITY(U,$J,358.3,6209,0)
 ;;=585.6^^37^438^10
 ;;^UTILITY(U,$J,358.3,6209,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6209,1,3,0)
 ;;=3^585.6
 ;;^UTILITY(U,$J,358.3,6209,1,4,0)
 ;;=4^ESRD
 ;;^UTILITY(U,$J,358.3,6209,2)
 ;;=^303986
 ;;^UTILITY(U,$J,358.3,6210,0)
 ;;=281.1^^37^439^2
 ;;^UTILITY(U,$J,358.3,6210,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6210,1,3,0)
 ;;=3^281.1
 ;;^UTILITY(U,$J,358.3,6210,1,4,0)
 ;;=4^ANEMIA,B12 DEF
 ;;^UTILITY(U,$J,358.3,6210,2)
 ;;=^267974
 ;;^UTILITY(U,$J,358.3,6211,0)
 ;;=281.2^^37^439^3
 ;;^UTILITY(U,$J,358.3,6211,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6211,1,3,0)
 ;;=3^281.2
 ;;^UTILITY(U,$J,358.3,6211,1,4,0)
 ;;=4^ANEMIA,FOLATE DEF
 ;;^UTILITY(U,$J,358.3,6211,2)
 ;;=^259686
 ;;^UTILITY(U,$J,358.3,6212,0)
 ;;=280.9^^37^439^4
 ;;^UTILITY(U,$J,358.3,6212,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6212,1,3,0)
 ;;=3^280.9
 ;;^UTILITY(U,$J,358.3,6212,1,4,0)
 ;;=4^ANEMIA,IRON DEF
 ;;^UTILITY(U,$J,358.3,6212,2)
 ;;=^276946
 ;;^UTILITY(U,$J,358.3,6213,0)
 ;;=285.8^^37^439^1
 ;;^UTILITY(U,$J,358.3,6213,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6213,1,3,0)
 ;;=3^285.8
 ;;^UTILITY(U,$J,358.3,6213,1,4,0)
 ;;=4^ANEMIA NEC
 ;;^UTILITY(U,$J,358.3,6213,2)
 ;;=^87876
 ;;^UTILITY(U,$J,358.3,6214,0)
 ;;=282.2^^37^439^5
 ;;^UTILITY(U,$J,358.3,6214,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6214,1,3,0)
 ;;=3^282.2
 ;;^UTILITY(U,$J,358.3,6214,1,4,0)
 ;;=4^G6Pd DEFICIENCY
 ;;^UTILITY(U,$J,358.3,6214,2)
 ;;=^7225
 ;;^UTILITY(U,$J,358.3,6215,0)
 ;;=V08.^^37^439^6
 ;;^UTILITY(U,$J,358.3,6215,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6215,1,3,0)
 ;;=3^V08.
 ;;^UTILITY(U,$J,358.3,6215,1,4,0)
 ;;=4^HIV+ (ASYMPTOMATIC)
 ;;^UTILITY(U,$J,358.3,6215,2)
 ;;=^303392
 ;;^UTILITY(U,$J,358.3,6216,0)
 ;;=279.3^^37^439^7
 ;;^UTILITY(U,$J,358.3,6216,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6216,1,3,0)
 ;;=3^279.3
 ;;^UTILITY(U,$J,358.3,6216,1,4,0)
 ;;=4^IMMUNITY DEFICIENCY NOS
 ;;^UTILITY(U,$J,358.3,6216,2)
 ;;=^267969
 ;;^UTILITY(U,$J,358.3,6217,0)
 ;;=785.6^^37^439^8
 ;;^UTILITY(U,$J,358.3,6217,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6217,1,3,0)
 ;;=3^785.6
 ;;^UTILITY(U,$J,358.3,6217,1,4,0)
 ;;=4^LYMPHADENOPATHY
 ;;^UTILITY(U,$J,358.3,6217,2)
 ;;=^72368
 ;;^UTILITY(U,$J,358.3,6218,0)
 ;;=075.^^37^439^9
 ;;^UTILITY(U,$J,358.3,6218,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6218,1,3,0)
 ;;=3^075.
 ;;^UTILITY(U,$J,358.3,6218,1,4,0)
 ;;=4^MONONUCLEOSIS
 ;;^UTILITY(U,$J,358.3,6218,2)
 ;;=^62797
 ;;^UTILITY(U,$J,358.3,6219,0)
 ;;=238.4^^37^439^10
 ;;^UTILITY(U,$J,358.3,6219,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6219,1,3,0)
 ;;=3^238.4
 ;;^UTILITY(U,$J,358.3,6219,1,4,0)
 ;;=4^POLYCYTHEMIA VERA
 ;;^UTILITY(U,$J,358.3,6219,2)
 ;;=^304816
 ;;^UTILITY(U,$J,358.3,6220,0)
 ;;=282.49^^37^439^11
 ;;^UTILITY(U,$J,358.3,6220,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6220,1,3,0)
 ;;=3^282.49
 ;;^UTILITY(U,$J,358.3,6220,1,4,0)
 ;;=4^THALASSEMIA NEC
 ;;^UTILITY(U,$J,358.3,6220,2)
 ;;=^329910
 ;;^UTILITY(U,$J,358.3,6221,0)
 ;;=287.5^^37^439^12
 ;;^UTILITY(U,$J,358.3,6221,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6221,1,3,0)
 ;;=3^287.5
 ;;^UTILITY(U,$J,358.3,6221,1,4,0)
 ;;=4^THROMBOCYTOPENIA NOS
 ;;^UTILITY(U,$J,358.3,6221,2)
 ;;=^118988
 ;;^UTILITY(U,$J,358.3,6222,0)
 ;;=289.9^^37^439^13
 ;;^UTILITY(U,$J,358.3,6222,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6222,1,3,0)
 ;;=3^289.9
 ;;^UTILITY(U,$J,358.3,6222,1,4,0)
 ;;=4^THROMBOCYTOSIS
 ;;^UTILITY(U,$J,358.3,6222,2)
 ;;=^55344
 ;;^UTILITY(U,$J,358.3,6223,0)
 ;;=401.9^^37^440^1
 ;;^UTILITY(U,$J,358.3,6223,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6223,1,3,0)
 ;;=3^401.9
 ;;^UTILITY(U,$J,358.3,6223,1,4,0)
 ;;=4^HYPERTENSION NOS
 ;;^UTILITY(U,$J,358.3,6223,2)
 ;;=^186630
 ;;^UTILITY(U,$J,358.3,6224,0)
 ;;=401.1^^37^440^3
 ;;^UTILITY(U,$J,358.3,6224,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6224,1,3,0)
 ;;=3^401.1
 ;;^UTILITY(U,$J,358.3,6224,1,4,0)
 ;;=4^HYPERTENSION,BENIGN
 ;;^UTILITY(U,$J,358.3,6224,2)
 ;;=^269591
 ;;^UTILITY(U,$J,358.3,6225,0)
 ;;=401.0^^37^440^2
 ;;^UTILITY(U,$J,358.3,6225,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6225,1,3,0)
 ;;=3^401.0
 ;;^UTILITY(U,$J,358.3,6225,1,4,0)
 ;;=4^HYPERTENSION,ACCELERATED
 ;;^UTILITY(U,$J,358.3,6225,2)
 ;;=^73505
 ;;^UTILITY(U,$J,358.3,6226,0)
 ;;=227.0^^37^441^1
 ;;^UTILITY(U,$J,358.3,6226,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6226,1,3,0)
 ;;=3^227.0
 ;;^UTILITY(U,$J,358.3,6226,1,4,0)
 ;;=4^ADRENAL NEOPLASM,BENIGN
 ;;^UTILITY(U,$J,358.3,6226,2)
 ;;=^267688
 ;;^UTILITY(U,$J,358.3,6227,0)
 ;;=194.0^^37^441^2
 ;;^UTILITY(U,$J,358.3,6227,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6227,1,3,0)
 ;;=3^194.0
 ;;^UTILITY(U,$J,358.3,6227,1,4,0)
 ;;=4^ADRENAL NEOPLASM,MALIGNANT
 ;;^UTILITY(U,$J,358.3,6227,2)
 ;;=^267298
 ;;^UTILITY(U,$J,358.3,6228,0)
 ;;=255.10^^37^441^3
 ;;^UTILITY(U,$J,358.3,6228,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6228,1,3,0)
 ;;=3^255.10
 ;;^UTILITY(U,$J,358.3,6228,1,4,0)
 ;;=4^ALDOSTERONISM
 ;;^UTILITY(U,$J,358.3,6228,2)
 ;;=^330019
 ;;^UTILITY(U,$J,358.3,6229,0)
 ;;=255.0^^37^441^4
 ;;^UTILITY(U,$J,358.3,6229,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6229,1,3,0)
 ;;=3^255.0
 ;;^UTILITY(U,$J,358.3,6229,1,4,0)
 ;;=4^CUSHING'S SYNDROME
 ;;^UTILITY(U,$J,358.3,6229,2)
 ;;=^29802
 ;;^UTILITY(U,$J,358.3,6230,0)
 ;;=403.90^^37^441^6
 ;;^UTILITY(U,$J,358.3,6230,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6230,1,3,0)
 ;;=3^403.90
 ;;^UTILITY(U,$J,358.3,6230,1,4,0)
 ;;=4^HTN RENAL w/o RENAL FAILURE NOS
 ;;^UTILITY(U,$J,358.3,6230,2)
 ;;=^334272
 ;;^UTILITY(U,$J,358.3,6231,0)
 ;;=403.91^^37^441^5
 ;;^UTILITY(U,$J,358.3,6231,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6231,1,3,0)
 ;;=3^403.91
 ;;^UTILITY(U,$J,358.3,6231,1,4,0)
 ;;=4^HTN RENAL w/ RENAL FAILURE NOS
 ;;^UTILITY(U,$J,358.3,6231,2)
 ;;=^334242
 ;;^UTILITY(U,$J,358.3,6232,0)
 ;;=405.91^^37^441^7
 ;;^UTILITY(U,$J,358.3,6232,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6232,1,3,0)
 ;;=3^405.91
 ;;^UTILITY(U,$J,358.3,6232,1,4,0)
 ;;=4^HTN RENOVASCULAR NOS
 ;;^UTILITY(U,$J,358.3,6232,2)
 ;;=^269634
 ;;^UTILITY(U,$J,358.3,6233,0)
 ;;=403.00^^37^441^9
 ;;^UTILITY(U,$J,358.3,6233,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6233,1,3,0)
 ;;=3^403.00
 ;;^UTILITY(U,$J,358.3,6233,1,4,0)
 ;;=4^MAL HTN RENAL w/o RENAL FAILURE
 ;;^UTILITY(U,$J,358.3,6233,2)
 ;;=^334270
 ;;^UTILITY(U,$J,358.3,6234,0)
 ;;=403.01^^37^441^8
 ;;^UTILITY(U,$J,358.3,6234,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6234,1,3,0)
 ;;=3^403.01
 ;;^UTILITY(U,$J,358.3,6234,1,4,0)
 ;;=4^MAL HTN RENAL w/ RENAL FAILURE
 ;;^UTILITY(U,$J,358.3,6234,2)
 ;;=^334240
 ;;^UTILITY(U,$J,358.3,6235,0)
 ;;=405.01^^37^441^10
 ;;^UTILITY(U,$J,358.3,6235,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6235,1,3,0)
 ;;=3^405.01
 ;;^UTILITY(U,$J,358.3,6235,1,4,0)
 ;;=4^MAL HTN RENOVASCULAR
 ;;^UTILITY(U,$J,358.3,6235,2)
 ;;=^269628
 ;;^UTILITY(U,$J,358.3,6236,0)
 ;;=404.91^^37^442^1
 ;;^UTILITY(U,$J,358.3,6236,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6236,1,3,0)
 ;;=3^404.91
 ;;^UTILITY(U,$J,358.3,6236,1,4,0)
 ;;=4^HTN HRT/REN w/ CHF,NOS
 ;;^UTILITY(U,$J,358.3,6236,2)
 ;;=^334249
 ;;^UTILITY(U,$J,358.3,6237,0)
 ;;=404.93^^37^442^2
 ;;^UTILITY(U,$J,358.3,6237,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6237,1,3,0)
 ;;=3^404.93
 ;;^UTILITY(U,$J,358.3,6237,1,4,0)
 ;;=4^HTN HRT/REN w/ CHR&RF,NOS
 ;;^UTILITY(U,$J,358.3,6237,2)
 ;;=^334251
 ;;^UTILITY(U,$J,358.3,6238,0)
 ;;=404.90^^37^442^4
 ;;^UTILITY(U,$J,358.3,6238,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6238,1,3,0)
 ;;=3^404.90
 ;;^UTILITY(U,$J,358.3,6238,1,4,0)
 ;;=4^HTN HRT/REN w/o CHF/RF,NOS
 ;;^UTILITY(U,$J,358.3,6238,2)
 ;;=^334275
 ;;^UTILITY(U,$J,358.3,6239,0)
 ;;=404.92^^37^442^3
 ;;^UTILITY(U,$J,358.3,6239,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6239,1,3,0)
 ;;=3^404.92
